Evidence map›Paper›PMID 38949024›Full record

ArticleThe Journal of clinical investigation2024

Primary cilia formation requires the Leigh syndrome-associated mitochondrial protein NDUFAF2.

Chien-Hui Lo, Zhiquan Liu, Siyu Chen, Frank Lin, Andrew R Berneshawi, Charles Q Yu, Euna B Koo, Tia J Kowal, Ke Ning, Yang Hu and 3 more

Abstract read
In one paragraph

Article in The Journal of clinical investigation, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Multi-Omics Reveals the Effects ofAntioxidants (Basel, Switzerland) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Chien-Hui LoDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Zhiquan LiuDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Siyu ChenDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Frank LinDepartment of Medicine, Stanford University, Palo Alto, California, USA.
Andrew R BerneshawiDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Charles Q YuDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Euna B KooDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Tia J KowalDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Ke NingDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Yang HuDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Won-Jing WangInstitute of Biochemistry and Molecular Biology, College of Life Science, National Yang Ming Chiao Tung University, Taipei, Taiwan.
Y Joyce LiaoDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.
Yang SunDepartment of Ophthalmology, Stanford University School of Medicine, Palo Alto, California, USA.

Funding

Stanford Vision Research CoreP30EY026877 · NEI · STANFORD UNIVERSITY · PI Alfredo Dubra · 2017 to 2026
$8.0M
Elucidating Neuron-Intrinsic Molecular Mechanisms of Optic Nerve RegenerationR01EY024932 · NEI · TEMPLE UNIV OF THE COMMONWEALTH · PI Yang Hu · 2015 to 2026
$4.8M
The role of primary cilia in glaucoma pathogenesisR01EY025295 · NEI · STANFORD UNIVERSITY · PI Yang Sun · 2016 to 2026
$3.5M
In Vivo Function and Metabolism Evaluation of Glaucomatous RGCs by Two-Photon Scanning Laser OphthalmologyR01EY034353 · NEI · STANFORD UNIVERSITY · PI Yang Hu, Hao F Zhang · 2023 to 2026
$2.7M
Optineurin dysfunction induces neurodegeneration in normal tension glaucoma by a novel molecular mechanismR01EY032518 · NEI · STANFORD UNIVERSITY · PI Yang Hu · 2022 to 2026
$2.7M
Developing Novel Neuroprotective Strategies for EAE/Optic NeuritisR01EY028106 · NEI · STANFORD UNIVERSITY · PI HU, YANG · 2018 to 2021
$1.9M
Phosphoinositide signaling in glaucoma: rescue strategies for Lowe syndromeR01EY032159 · NEI · STANFORD UNIVERSITY · PI SUN, YANG · 2021 to 2024
$1.6M
Glaucoma Pathogenesis of Oculocerebrorenal syndrome of LoweK08EY022058 · NEI · STANFORD UNIVERSITY · PI SUN, YANG · 2012 to 2016
$994k
Purchase of a Q Exactive HF mass spectrometer system for metabolomicsS10OD023586 · OD · WISTAR INSTITUTE · PI SPEICHER, DAVID W. · 2017 to 2017
$600k
Primary Cilia of Astrocytes in GlaucomaK99EY034932 · NEI · STANFORD UNIVERSITY · PI NING, KE VERONICA · 2023 to 2024
$248k
NEI NIH HHS K08 EY022058NEI NIH HHS K99 EY034932NEI NIH HHS P30 EY026877NEI NIH HHS R01 EY024932NEI NIH HHS R01 EY025295NEI NIH HHS R01 EY028106NEI NIH HHS R01 EY032159NEI NIH HHS R01 EY032518NEI NIH HHS R01 EY034353NIH HHS S10 OD023586
6 · The paper itself

Abstract

Mitochondria-related neurodegenerative diseases have been implicated in the disruption of primary cilia function. Mutation in an intrinsic mitochondrial complex I component NDUFAF2 has been identified in Leigh syndrome, a severe inherited mitochondriopathy. Mutations in ARMC9, which encodes a basal body protein, cause Joubert syndrome, a ciliopathy with defects in the brain, kidney, and eye. Here, we report a mechanistic link between mitochondria metabolism and primary cilia signaling. We discovered that loss of NDUFAF2 caused both mitochondrial and ciliary defects in vitro and in vivo and identified NDUFAF2 as a binding partner for ARMC9. We also found that NDUFAF2 was both necessary and sufficient for cilia formation and that exogenous expression of NDUFAF2 rescued the ciliary and mitochondrial defects observed in cells from patients with known ARMC9 deficiency. NAD+ supplementation restored mitochondrial and ciliary dysfunction in ARMC9-deficient cells and zebrafish and ameliorated the ocular motility and motor deficits of a patient with ARMC9 deficiency. The present results provide a compelling mechanistic link, supported by evidence from human studies, between primary cilia and mitochondrial signaling. Importantly, our findings have significant implications for the development of therapeutic approaches targeting ciliopathies.

Indexed as

CiliaKidney Diseases, CysticLeigh DiseaseMitochondriaZebrafishAbnormalities, MultipleAnimalsArmadillo Domain ProteinsCerebellumElectron Transport Complex IEye AbnormalitiesHumansMaleMiceMitochondrial ProteinsRetinaArmadillo Domain ProteinsElectron Transport Complex IMitochondrial ProteinsZebrafish ProteinsCell biologyNeurodegenerationNeurological disordersOphthalmologyRetinopathy

Identifiers

PMID38949024
PMCPMC11213510

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.